Inhibition of placenta growth factor with TB-403: a novel antiangiogenic cancer therapy.
about
Synergistic Effect of Anti-Angiogenic and Radiation Therapy: Quantitative Evaluation with Dynamic Contrast Enhanced MR Imaging.Targeting placental growth factor/neuropilin 1 pathway inhibits growth and spread of medulloblastoma.Placental growth factor in cancer.Anti-angiogenic agents for the treatment of solid tumors: Potential pathways, therapy and current strategies - A review.
P2860
Inhibition of placenta growth factor with TB-403: a novel antiangiogenic cancer therapy.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Inhibition of placenta growth factor with TB-403: a novel antiangiogenic cancer therapy.
@en
type
label
Inhibition of placenta growth factor with TB-403: a novel antiangiogenic cancer therapy.
@en
prefLabel
Inhibition of placenta growth factor with TB-403: a novel antiangiogenic cancer therapy.
@en
P2860
P1476
Inhibition of placenta growth factor with TB-403: a novel antiangiogenic cancer therapy.
@en
P2093
Dorte Lisbet Nielsen
Lisa Sengeløv
P2860
P304
P356
10.1517/14712598.2012.679655
P407
P577
2012-04-16T00:00:00Z